Increase in congenital rubella occurrence after immunisation in Greece: Retrospective survey and systematic review

British Medical Journal

Volumn 319, Issue 7223, 1999, Pages 1462-1466

  Panagiotopoulos, Takis ^a   Antoniadou, Ioanna ^a   Valassi Adam, Eleni ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL RUBELLA SYNDROME; DISEASE PREDISPOSITION; EPIDEMIC; FEMALE; GREECE; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GREECE; HUMANS; IMMUNIZATION; INFANT; MALE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; VACCINES, COMBINED;

EID: 0033524142     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 1 Cooper LZ. The history and medical consequences of rubella. Rev Infect Dis 1985;7(suppl I):2-10S.
2. 2 Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-4.
3. 3 Best JM. Rubella vaccines: past, present and future. Epidemiol Infect 1991;107:17-30.
4. 4 Knox EG. Theoretical aspects of rubella vaccination. Rev Infect Dis 1985;7(suppl I):194-7S.
5. 5 Bart KJ, Orenstein WA, Preblud SR, Hinman AR. Universal immunization to interrupt rubella. Rev Infect Dis 1985;7(suppl I):177-84S.
6. 6 Knox EG, Strategy for rubella vaccination. Int J Epidemiol 1980;9:13-23.
7. 7 Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigation of different policies. J Hyg (Camb) 1983;90:259-325.
8. 8 Hethcote JW. Measles and rubella in the United States. Am J Epidemiol 1983;117:2-13.
9. 9 Van Druten JAM, de Boo T, Plantinga AD. Measles, mumps and rubella: control by vaccination. Dev Biol Stand 1986;65:53-63.
10. 10 Dudjeon JA. Selective immunization: protection of the individual. Rev Infect Dis 1985;7(suppl I):185-90S.
11. 11 Bötiger M, Forsgren M. Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum and 13 years of a general two-dose vaccination. Vaccine 1997;15:1538-41.
12. 12 Center for Disease Control. Rubella prevention. Recommendations of the Immunization Practices Advisory Committee. MMWR Morb Mortal Wkly Rep 1990;39(RR-15):1-18.
13. 13 A second dose of MMR vaccine for children in the United Kingdom. Common Dis Rep CDR Wkly 1996;6:259.
14. 14 Robertson SE, Cutts FT, Samuel R, Diaz-Ortega J-L. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2: vaccination against rubella. Bull World Health Organ 1997;75:69-80.
15. 15 Cutts FT, Robertson SE, Diaz-Ortega J-L, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 1: burden of disease from CRS. Bull World Health Organ 1997;75:55-68.
16. 16 World Health Organisation. Health for all targets. The health policy for Europe. European Health for All Series, No 4. Copenhagen: WHO, 1991:31-3.
17. 17 De la Malta I, De Wals P. Policies for immunization against rubella in European countries. Eur J Epidemiol 1988;4:175-80.
18. 18 National Statistical Service of Greece. Monthly statistical bulletin (years 1060 to 1995). Athens: NSSG.
19. 19 Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Major epidemic of congenital rubella in Greece in 1993: a serious public health problem. Report on a study of the Institute of Child Health. Athens: Institute of Child Health; Dec 1995. (In Greek.)
20. 20 Panagiotopoulos T, Antoniadou I, Antonopoulou E, Gogoglou V, Tousani S, Lakaki E, et al. Increase of age at infection in Atliki (Greece) during the rubella epidemic of 1993. Arch Hellenic Med 1996;13:211-9. (In Greek.)
21. 21 Panagiotopoulos T, Antoniadou I, Delis D, Giannakos A, Chrysomallou P, Bartsokas C, et al. Increase of age at infection in the childhood population of Athens during the rubella epidemic of 1993. Ann Clin Paedeatr Univ Atluniensis 1995;42:175-80. (In Greek.)
22. 22 Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Congenital rubella syndrome epidemic in Greece in 1993. A report of 25 confirmed cases. Paediatrika 1997;60:582-91. (In Greek.)
23. 23 Orenstein WA, Preblud SR, Bart KJ, Hinman AR. Methods for assessing the impact of rubella infection. Rev Dis 1985;7(suppl I):22-8S.
24. 24 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 1998;351:637-41. (2 September 1999)